Skip to main content

Table 3 Clinical variables in 441 lung adenocarcinoma patients included in survival analysis.

From: MUC1-associated proliferation signature predicts outcomes in lung adenocarcinoma patients

Clinical variable Categories Number of patients
T stage T1-2 399
  T3-4 40
N stage Nodes uninvolved (N0) 299
  Nodes involved (N1-2) 139
Tumor grade Low grade (1) 60
  Intermediate or high grade (2-3) 374
Our classifier (MAPS) MAPS- 229
  MAPS+ (Expressor) 211